Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance

Heron Therapeutics IncTrade
ZIM Integrated Shipping Services LtdTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs ZIM Integrated Shipping Services Ltd — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while ZIM Integrated Shipping Services Ltd trades at $24.73 (market cap $2.93B). The key difference: ZIM Integrated Shipping Services Ltd is far larger — about 32× Heron Therapeutics Inc's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

HRTXZIM
Market Cap
$91.46M$2.93B
Sector
HealthIndustrials
52-Week High
$1.96$29.27
52-Week Low
$0.39$12.44
Enterprise Value
$189.36M$6.78B
Dividend Yield
20.16%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

ZIM Integrated Shipping Services Ltd

ZIM Integrated Shipping Services trades at $24.31, showing minimal daily movement with a 0.04% gain. The stock faces bearish technical signals and mixed analyst sentiment, with equal hold and sell ratings. Recent financials show declining revenue from $6.9B in 2025 to $6.3B projected for 2026, while net income dropped sharply from $479M to $98M. The company maintains strong cash flow from operations but faces challenges from regulatory setbacks in the Hapag-Lloyd acquisition and volatile freight rates.

ZIM presents a cautious outlook with significant downside risk to the $16.75 consensus price target. While valuation metrics appear attractive with P/S of 0.47 and P/B of 0.77, declining profitability and regulatory uncertainty offset potential upside. The key opportunity lies in resolution of merger negotiations, while risks include sustained freight rate pressure and ongoing cash burn trends.

Returns comparison

Trailing returns across standard periods

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About ZIM Integrated Shipping Services Ltd

ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.

Read more on ZIM